Dermatologists review FDA's updated sunscreen guidelines
The Food and Drug Administration (FDA) has released its long-awaited updated guidelines for sunscreens earlier this summer, and as hoped, more definitive standards were set delineating which sunscreens can designate themselves as having "broad-spectrum" protection from both UVA and UVB rays.
The guidelines also ban the use of SPF designations over 50 and claims of sunscreens to be waterproof or sweatproof. They also call for warnings that sunscreens should be reapplied regularly, especially after swimming or sweating.
On Call asked dermatologists around the country what they think of the new guidelines and whether they go far enough.
"I had a two-fold reaction," she says. "One, it certainly is an improvement over what we have now. As a person who practices in rural Kansas, which has a huge Armenian community, we see a lot of problems with just basic information about sunscreen. People don't know what the terms mean; they don't know how much they need. They're spending money on things they shouldn't be spending money on, without knowing what value they're getting.
"Rural Kansas is a strong outdoor area," she says. "We're very fiscally conservative and like to know we're getting good value for our money. So although these regulations help, they're not as clear as many dermatologists, including myself, would like them to be."
"I'm really glad that they have defined for the industry what 'broad spectrum' means," Dr. Forney says. "We know what SPF means, and you can decide which is the best one for you, but the whole idea of a broad-spectrum and UVA protection has never been defined. My understanding is that they've now said that broad spectrum means that 90 percent of UVA rays are blocked. We've never had a quantifiable definition of UVA protection, so that's the best thing that's come out of this, in my opinion."
Daniel Ladd, D.O., in Austin, Texas, agrees on the importance of the board-spectrum definition.
"I actually think there will benefits because all (that) my patients are focused on is the SPF number," he says. "That only reflects the UVB protection. UVA can cause cancer and premature aging, so I think it's important for patients to start looking for sunscreens that have UVA and UVB protection.
"If the FDA is willing to make it clearer by calling something that contains the appropriate amount of both UVA and UVB protection 'broad spectrum,' I think it's helpful to have a uniform way to make it clear what they're looking for," Dr. Ladd adds.
"Patients like the SPF number because it gives them a sense that they have some control over how much strength their purchasing, but there are studies out there that show that anything above 30 doesn't really do much more, anyway. But it gives them a sense of control and will allow them to have a sense that they are making a choice. If they're going to be out all day in the sun, they will probably pick a larger number," Dr. Ladd says.
MORE ARTICLES IN THIS ISSUE
Chronic urticaria can be difficult to treat, but new and evolving therapeutic options can effectively manage symptoms. Treating the cause of chronic urticaria is one of the primary goals of therapy, but very often the cause is not found. Chronic idiopathic urticaria is the diagnosis given to those patients where the etiology remains unknown.
There's no better time than now to take a fresh look at opportunities to boost your bottom line. Whether it's saving money or earning more, these missed opportunities may be right under your nose. Regardless of the size of your dermatology practice or its position in the local healthcare market, you are likely finding the margin between revenues and expenses is getting narrower and narrower.
There are very few therapies approved to treat hair loss in women, compelling clinicians to turn to off-label therapies to address this condition, according to the president of the North American Hair Research Society. "Limited drugs are available," says Wilma F. Bergfeld, M.D., senior dermatologist, department of dermatology, Cleveland Clinic, Cleveland.
Adult women comprise a growing percentage of the patient population that dermatologists see with acne, and today, many treatment regimens are available and customizable to each patient's needs, according to Diane S. Berson, M.D., president, Women's Dermatologic Society, and assistant professor of dermatology, Cornell Medical College, New York.
In refractory cases of localized, provoked vulvodynia, botulinum toxin type A can be considered a therapeutic option, according to Jennifer MacGregor, M.D., of Washington Institute of Dermatologic Laser Surgery, Washington.